Arcadia Biosciences, Inc.
RKDA
$3.40
-$0.0813-2.34%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.88M | 4.64M | 4.63M | 4.60M | 4.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.88M | 4.64M | 4.63M | 4.60M | 4.57M |
| Cost of Revenue | 2.82M | 2.59M | 2.63M | 2.58M | 2.86M |
| Gross Profit | 2.06M | 2.04M | 2.00M | 2.02M | 1.72M |
| SG&A Expenses | 9.81M | 9.43M | 8.82M | 9.70M | 11.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.62M | 12.02M | 11.44M | 12.28M | 14.49M |
| Operating Income | -7.75M | -7.38M | -6.82M | -7.68M | -9.92M |
| Income Before Tax | -2.20M | -1.66M | -351.00K | -7.13M | -9.85M |
| Income Tax Expenses | 7.00K | 7.00K | 8.00K | 8.00K | 14.00K |
| Earnings from Continuing Operations | -2.21 | -1.66 | -0.36 | -7.14 | -9.87 |
| Earnings from Discontinued Operations | -3.62M | -5.12M | -6.67M | -6.85M | -5.59M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00 | 0.00 | 5.00K | 5.00K | 89.00K |
| Net Income | -5.83M | -6.78M | -7.02M | -13.98M | -15.37M |
| EBIT | -7.75M | -7.38M | -6.82M | -7.68M | -9.92M |
| EBITDA | -7.59M | -7.15M | -6.55M | -7.39M | -9.61M |
| EPS Basic | -4.28 | -4.98 | -5.16 | -14.23 | -18.44 |
| Normalized Basic EPS | -2.71 | -2.46 | -0.02 | -5.59 | -6.95 |
| EPS Diluted | -4.28 | -4.98 | -5.16 | -14.24 | -18.44 |
| Normalized Diluted EPS | -2.71 | -2.46 | -0.02 | -5.59 | -6.95 |
| Average Basic Shares Outstanding | 5.45M | 5.45M | 5.44M | 4.94M | 4.26M |
| Average Diluted Shares Outstanding | 5.45M | 5.45M | 5.44M | 4.94M | 4.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
